Literature DB >> 12699423

Evaluation of amastigote reactive cells in human cutaneous leishmaniasis caused by Leishmania aethiopica.

K Maasho1, D McMahon-Pratt, J Raita, M Raud, S Britton, L Soong, H Akuffo.   

Abstract

Lymphoproliferative responses to three affinity chromatography purified amastigote antigens of Leishmania pifanoi, P-2, P-4 and P-8, were evaluated in peripheral blood mononuclear cells (PBMC) from patients with Ethiopian cutaneous leishmaniasis. Antigen-stimulated cells were analysed for the percentage of CD4+, CD8+ and CD16/56+ cells and the expressed levels of gamma interferon (IFNgamma) and interleukin (IL)-10 were determined in culture supernatants. The amastigote antigens induced cellular responses in leishmaniasis patients with heterologous Leishmania parasite infection. These responses were compared to those of freeze-thawed L. aethiopica promastigote antigen stimulation. The membrane protein (P-8), and to a lesser extent the megasomal/cytoplasmic cysteine proteinase(P-2), induced proliferation with high levels of IFNgamma and IL-10 production in cells from patients with active L. aethiopica lesions. CD16/56+ NK cells were the main cell types induced to proliferate in response to P-8 and P-2 stimulation, followed by CD8+ cell populations. P-4 had no such effect. This contrasts from previous studies of New World human leishmaniasis where P-4 and P-8 were stimulatory. The success of a particular molecule in the induction of a response with a protective phenotype may be dependent on the infecting Leishmania spp. To our knowledge, there are no studies that directly compare the New versus Old World cutaneous leishmaniasis in respect of NK cell and IL-10 responses. Our studies indicate that some leishmanial molecules are recognized across the species, while others are apparently more species specific.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12699423      PMCID: PMC1808716          DOI: 10.1046/j.1365-2249.2003.02165.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Presentation via the class I pathway by Leishmania amazonensis-infected macrophages of an endogenous leishmanial antigen to CD8+ T cells.

Authors:  P E Kima; N H Ruddle; D McMahon-Pratt
Journal:  J Immunol       Date:  1997-08-15       Impact factor: 5.422

2.  T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.

Authors:  S G Coutinho; M P Oliveira; A M Da-Cruz; P M De Luca; S C Mendonça; A L Bertho; L Soong; D McMahon-Pratt
Journal:  Exp Parasitol       Date:  1996-11       Impact factor: 2.011

3.  Leishmania aethiopica derived from diffuse leishmaniasis patients preferentially induce mRNA for interleukin-10 while those from localized leishmaniasis patients induce interferon-gamma.

Authors:  H Akuffo; K Maasho; M Blostedt; B Höjeberg; S Britton; M Bakhiet
Journal:  J Infect Dis       Date:  1997-03       Impact factor: 5.226

4.  Indications of the protective role of natural killer cells in human cutaneous leishmaniasis in an area of endemicity.

Authors:  K Maasho; F Sanchez; E Schurr; A Hailu; H Akuffo
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

5.  Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis.

Authors:  L Soong; S M Duboise; P Kima; D McMahon-Pratt
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

6.  Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein, gp63, of L. major.

Authors:  D Xu; F Y Liew
Journal:  Immunology       Date:  1995-02       Impact factor: 7.397

7.  The biosynthesis, processing, and immunolocalization of Leishmania pifanoi amastigote cysteine proteinases.

Authors:  S M Duboise; M A Vannier-Santos; D Costa-Pinto; L Rivas; A A Pan; Y Traub-Cseko; W De Souza; D McMahon-Pratt
Journal:  Mol Biochem Parasitol       Date:  1994-11       Impact factor: 1.759

8.  Leishmania pifanoi amastigote antigen P-4: epitopes involved in T-cell responsiveness in human cutaneous leishmaniasis.

Authors:  J E Haberer; A M Da-Cruz; L Soong; M P Oliveira-Neto; L Rivas; D McMahon-Pratt; S G Coutinho
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

9.  Natural and acquired resistance to Leishmania: cellular activation by Leishmania aethiopica of mononuclear cells from unexposed individuals is through the stimulation of natural killer (NK) cells.

Authors:  H Akuffo; K Maasho; R Howe
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

10.  Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major.

Authors:  S Gurunathan; D L Sacks; D R Brown; S L Reiner; H Charest; N Glaichenhaus; R A Seder
Journal:  J Exp Med       Date:  1997-10-06       Impact factor: 14.307

View more
  3 in total

1.  Mononuclear cells from patients recovered from cutaneous leishmaniasis respond to Leishmania major amastigote class I nuclease with a predominant Th1-like response.

Authors:  S Farajnia; F Mahboudi; S Ajdari; N E Reiner; A Kariminia; M H Alimohammadian
Journal:  Clin Exp Immunol       Date:  2005-03       Impact factor: 4.330

Review 2.  Natural killer cells in experimental and human leishmaniasis.

Authors:  Christian Bogdan
Journal:  Front Cell Infect Microbiol       Date:  2012-05-29       Impact factor: 5.293

3.  The Anti-leishmanial Efficacy of Artemisia dracunculus Ethanolic Extract in Vitro and Its Effects on IFN-γ and IL-4 Response.

Authors:  Reza Rezaei; Khosrow Hazrati Tappeh; Shahram Seyyedi; Peyman Mikaili
Journal:  Iran J Parasitol       Date:  2017 Jul-Sep       Impact factor: 1.012

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.